A detailed history of Vivo Capital, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Vivo Capital, LLC holds 1,105,454 shares of SLN stock, worth $7.74 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares
1,105,454
Previous 1,105,454 -0.0%
Holding current value
$7.74 Million
Previous $21 Million 4.26%
% of portfolio
2.94%
Previous 3.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$17.39 - $26.25 $10.4 Million - $15.6 Million
595,250 Added 116.67%
1,105,454 $23.9 Million
Q4 2023

Feb 06, 2024

BUY
$6.7 - $17.67 $3.42 Million - $9.02 Million
510,204 New
510,204 $8.86 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $251M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.